| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | -42.3% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | -1958.9% |
| Gross margin | 19.8% | Net margin -15.7% |
| Revenue Q/Q | -25.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 80.2% |
| R&D | ¥0.01B | 4.5% |
| SG&A | ¥0.04B | 29.6% |
| Tax & other | ¥0.00B | 0.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
迈为股份 ・ 隆利科技 ・ 爱朋医疗 ・ 华致酒行 ・ 金马游乐 ・ 罗博特科 ・ 七彩化学 ・ 康龙化成 ・ 立华股份 ・ 上海瀚讯 ・ 锦浪科技 ・ 石药创新
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies